# Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma

Source: https://onco.cc/trials/nct02755311/  
OnCo record `nct02755311` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Carboplatin and Ethiodized oil in Hepatocellular carcinoma, run by Sun Yat-sen University, with a status the registry has not verified recently.

## Summary

Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma is a phase 3 interventional study registered as NCT02755311 by Sun Yat-sen University, with 198 participants planned, started 2014-03 and due to reach its primary completion in 2016-06. Interventions recorded: liver resection, transarterial chemoembolization, carboplatin, lipiodol, epirubicin, pirarubicin, hydroxycamptothecin and fluorouracil, absorbable gelatin sponge particles. Conditions recorded: Hepatocellular Carcinoma.

Linked to the drug Ethiodized oil because the registry names it among its interventions and Hepatocellular carcinoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT02755311
- Phase: 3
- Setting: Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma: a Prospective Non-randomized Trial
- Sponsor: Sun Yat-sen University
- Enrolled: 198

## Sources

- ClinicalTrials.gov NCT02755311: https://clinicaltrials.gov/study/NCT02755311

## Connected records

- cancers: [Hepatocellular carcinoma](https://onco.cc/cancers/hcc/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Ethiodized oil](https://onco.cc/drugs/ethiodized-oil/)

---
JSON: https://onco.cc/api/v1/entities/nct02755311.json